Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.04M Buy
40,205
+3,647
+10% +$185K 0.2% 71
2017
Q2
$1.97M Buy
36,558
+1,973
+6% +$105K 0.2% 71
2017
Q1
$1.82M Sell
34,585
-1
-0% -$51 0.19% 70
2016
Q4
$1.67M Buy
34,586
+2,649
+8% +$131K 0.18% 70
2016
Q3
$1.72M Buy
31,937
+878
+3% +$48.1K 0.19% 73
2016
Q2
$1.68M Buy
31,059
+1,068
+4% +$56.3K 0.19% 75
2016
Q1
$1.52M Buy
29,991
+1,336
+5% +$66.5K 0.18% 75
2015
Q4
$1.45M Sell
28,655
-4,251
-13% -$217K 0.18% 75
2015
Q3
$1.58M Buy
32,906
+2,768
+9% +$144K 0.2% 63
2015
Q2
$1.57M Buy
30,138
+1,052
+4% +$59.2K 0.18% 69
2015
Q1
$1.68M Buy
29,086
+2,754
+10% +$158K 0.18% 55
2014
Q4
$1.41M Buy
26,332
+2,829
+12% +$158K 0.15% 69
2014
Q3
$1.35M Buy
23,503
+2,472
+12% +$152K 0.15% 66
2014
Q2
$1.41M Buy
21,031
+5,154
+32% +$349K 0.15% 60
2014
Q1
$1.06M Buy
15,877
+1,935
+14% +$131K 0.12% 74
2013
Q4
$930K Buy
13,942
+1,520
+12% +$98.6K 0.1% 74
2013
Q3
$779K Buy
12,422
+2,327
+23% +$150K 0.09% 82
2013
Q2
$631K Buy
+10,095
New +$641K 0.08% 93

Other funds holding GSK

BancorpSouth's GSK Position: Q3 2017 in Review

BancorpSouth increased its GSK (GSK) stake by 10% in Q3 2017, buying an estimated $185K and bringing the position to 40,205 shares worth $2.04M. The position accounts for 0.2% of the portfolio, ranked #71.

BancorpSouth first reported a position in GSK in Q2 2013 and has held it in 18 quarters since. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • BancorpSouth held 40,205 shares of GSK worth $2.04M as of Q3 2017.
  • BancorpSouth bought 3,647 GSK shares in Q3 2017, an estimated $185K.
  • GSK made up 0.2% of BancorpSouth's portfolio in Q3 2017, its #71 holding.
  • BancorpSouth first reported a position in GSK in Q2 2013 and has held it in 18 quarters since.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.